Combined PENG and LFCN Block for Total Hip Arthroplasty

Antwerp University Hospital (UZA)

Status: Completed

Conditions: Arthroplasty, Replacement, Hip; Anesthesia, Conduction; Pain, Postoperative

Treatments: Drug: Ropivacaine injection; Procedure: PENG + LFCN block

Study type: Interventional

Funder types: Other

Identifiers

NCT04996290

B3002020000032

Details and patient eligibility

About

A clinical trial investigating the effect of a combined locoregional anesthesia technique on the postoperative analgesia outcomes after a total hip arthroplasty. A PENG block will be used in combination with a LFCN block. The results will be compared to a control group that is solely treated with intravenous analgesia. This technique aims to provide improved pain scores after surgery without interference of revalidation.

Enrollment: 40 patients

Sex: All

Ages: 18 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• adult patients who underwent a primary total hip replacement under general anesthesia

Exclusion criteria

• insulin dependent diabetes mellitus
• chronic pain
• severe dementia or mental retardation
• allergy to local anesthetics

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

40 participants in 2 patient groups

PENG + LFCN block

Active Comparator group

Description:

The participants in this group received a combined regional technique just before surgery: * Pericapsular nerve group (PENG) block * Lateral femoral cutaneus nerve (LFCN) block

Treatment:

Procedure: PENG + LFCN block

Drug: Ropivacaine injection

No regional anesthesia

No Intervention group

Description:

Control group